Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCC4 | O15439 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | ACLY | P53396 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4013371 | 0.87 | MAPT (0.48) | ABCC4MAPTALDH1A1TSHRLMNA | |
| SCHEMBL4017942 | 0.83 | MAPT (0.50) | ABCC4MAPTALDH1A1TSHRLMNA | |
| SCHEMBL27039983 | 0.81 | MAPT (0.54) | ABCC4MAPTALDH1A1TSHRLMNA | |
| SCHEMBL29145661 | 0.79 | ABCC4 (0.39) | ABCC4MAPTALDH1A1TSHRLMNA | |
| SCHEMBL7094957 | 0.75 | GRM2 (0.31) | TSHR | |
| SCHEMBL8385882 | 0.75 | ACLY (0.38) | ABCC4MAPTALDH1A1TSHRLMNA | |
| SCHEMBL2292176 | 0.75 | ACLY (0.52) | ABCC4MAPTALDH1A1TSHRLMNA | |
| SCHEMBL6059309 | 0.75 | TET2 (0.45) | ABCC4MAPTALDH1A1TSHRLMNA | |
| SCHEMBL11530285 | 0.75 | ABCC4 (0.37) | ABCC4MAPTALDH1A1TSHR | |
| SCHEMBL14567209 | 0.75 | ABCC4 (0.47) | ABCC4MAPTALDH1A1TSHRLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10240011-B2 | Multifunctional curing agents and their use in improving strength of composites containing carbon fibers embedded in polymeric matrix | UT-BATTELLE, LLC (US) | 2019-03-26 | — | — | US | disclosed |
| US-20170166712-A1 | MULTIFUNCTIONAL CURING AGENTS AND THEIR USE IN IMPROVING STRENGTH OF COMPOSITES CONTAINING CARBON FIBERS EMBEDDED IN POLYMERIC MATRIX | UT-BATTELLE, LLC (US) | 2017-06-15 | — | — | US | disclosed |
| US-9617398-B2 | Multifunctional curing agents and their use in improving strength of composites containing carbon fibers embedded in a polymeric matrix | UT-BATTELLE, LLC (US) | 2017-04-11 | — | — | US | disclosed |
| EP-2885310-B1 | NOVEL METAL COMPLEXES, ESPECIALLY THE RUTHENIUM COMPLEXES, AND USE THEREOF | APEIRON SYNTHESIS SA (PL) | 2016-12-14 | — | — | EP | disclosed |
| US-20160102180-A1 | MULTIFUNCTIONAL CURING AGENTS AND THEIR USE IN IMPROVING STRENGTH OF COMPOSITES CONTAINING CARBON FIBERS EMBEDDED IN A POLYMERIC MATRIX | UT-BATTELLE, LLC (US) | 2016-04-14 | — | — | US | disclosed |
| US-9221042-B2 | Metal complexes, especially the ruthenium complexes, and use thereof | APEIRON SYNTHESIS S.A. (PL) | 2015-12-29 | — | — | US | disclosed |
| US-20150217283-A1 | NOVEL METAL COMPLEXES, ESPECIALLY THE RUTHENIUM COMPLEXES, AND USE THEREOF | APEIRON SYNTHESIS S.A. (PL) | 2015-08-06 | — | — | US | disclosed |
| EP-2885310-A1 | NOVEL METAL COMPLEXES, ESPECIALLY THE RUTHENIUM COMPLEXES, AND USE THEREOF | Apeiron Synthesis S.A. (PL) | 2015-06-24 | — | — | EP | disclosed |
| WO-2014027040-A1 | NOVEL METAL COMPLEXES, ESPECIALLY THE RUTHENIUM COMPLEXES, AND USE THEREOF | UNIWERSYTET WARSZAWSKI (PL) | 2014-02-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150217283-A1 | NOVEL METAL COMPLEXES, ESPECIALLY THE RUTHENIUM COMPLEXES, AND USE THEREOF | ABCB7, AP1M1, NDUFS5 | ABCC4 1972/4885MAPT 3428/4885ALDH1A1 796/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.